InsidersTradesSigma
Browse the full insider trade history of Acasti Pharma Inc., a publicly traded company based in United States. Shares trade on US US, under the authority of SEC (Form 4). The latest transaction was reported on 27 September 2023 (Acquisition). Among the most active insiders: Kavuru Vimal. Every trade is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
2 of 2 declarations